SHPAX (SHPAX) Stock Price & Analysis
SHPAX (SHPAX) fell 0.65% to USD 21.37 as of June 11, 2026 at 03:35 UTC, according to Nexqual real-time market data.
SHPAX last closed at USD 21.51; the session ranged USD 21.37–21.37 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 18.18–22.75 (NAS). Source: Nexqual, June 11, 2026 at 03:35 UTC.
Key Statistics (as of June 11, 2026 at 03:35 UTC)
| Price | USD 21.37 |
|---|---|
| Change | ▼ 0.65% (down) |
| Previous Close | USD 21.51 |
| Open | USD 21.37 |
| Day Range | USD 21.37 – 21.37 |
| 52-Week Range | USD 18.18 – 22.75 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (SHPAX)
Nexqual's technical model rates SHPAX "BUY" based on 5 bullish and 1 bearish signals across 123 daily candles, as of June 11, 2026 at 03:35 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 56.57 (neutral) |
| vs SMA50 | Above (USD 21.19) |
| MACD | 0.04 (positive) |
Financial Health Score (SHPAX)
Nexqual rates SHPAX's overall financial health "Mixed" across five dimensions, as of June 11, 2026 at 03:35 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LOGSX | Live Oak Health Sciences Fund | USD 23.8 | ▲ 0.76% |
| SBHIX | Saratoga Advantage Trust: Healt | USD 26.01 | ▲ 0.74% |
| SHPCX | Saratoga Advantage Tr Health & | USD 13.96 | ▲ 0.72% |
| RYBOX | Rydex Series Fds, Biotechnology | USD 64.77 | ▲ 0.06% |
| SUHAX | DWS Health and Wellness Fund - | USD 36.7 | ▲ 0.16% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 11, 2026 at 03:35 UTC. This page is informational and not investment advice.